LSD1 inhibition: a therapeutic strategy in cancer?

Bibliography

• Available from: www.sanger.ac.uk/genetics/CGP/Census/
   Google Scholar
• Guenther MG, Lawton LN, Rozovskaia T, Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia. Genes Dev 2008;22:3403-8
   PubMed Web of Science ®Google Scholar
• Bernt KM, Zhu N, Sinha AU, MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. Cancer Cell 2011;20:66-78
   PubMed Web of Science ®Google Scholar
• Fenaux P, Mufti GJ, Hellstrom-Lindberg E, Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncol 2009;10:223-32
   PubMed Web of Science ®Google Scholar
• Shi Y, Lan F, Matson C, Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004;119:941-53
   PubMed Web of Science ®Google Scholar
• Chen Y, Yang Y, Wang F, Crystal structure of human histone lysine-specific demethylase 1 (LSD1). Proc Natl Acad Sci USA 2006;103:13956-61
   PubMed Web of Science ®Google Scholar
• Stavropoulos P, Blobel G, Hoelz A. Crystal structure and mechanism of human lysine-specific demethylase-1. Nat Struct Mol Biol 2006;13:626-32
   PubMedGoogle Scholar
• Wang Y, Zhang H, Chen Y, LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell 2009;138:660-72
   PubMed Web of Science ®Google Scholar
• Tsukada Y, Fang J, Erdjument-Bromage H, Histone demethylation by a family of JmjC domain-containing proteins. Nature 2006;439:811-16
   PubMed Web of Science ®Google Scholar
• Hakimi MA, Dong Y, Lane WS, A candidate X-linked mental retardation gene is a component of a new family of histone deacetylase-containing complexes. J Biol Chem 2003;278:7234-9
   PubMed Web of Science ®Google Scholar
• Shi YJ, Matson C, Lan F, Regulation of LSD1 histone demethylase activity by its associated factors. Mol Cell 2005;19:857-64
   PubMed Web of Science ®Google Scholar
• Lee MG, Wynder C, Cooch N, An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature 2005;437:432-5
   PubMed Web of Science ®Google Scholar
• Ruepp A, Waegele B, Lechner M, CORUM: the comprehensive resource of mammalian protein complexes–2009. Nucleic Acids Res 2010;38:D497-501
   PubMed Web of Science ®Google Scholar
• Tong JK, Hassig CA, Schnitzler GR, Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature 1998;395:917-21
   PubMed Web of Science ®Google Scholar
• Humphrey GW, Wang Y, Russanova VR, Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-L1. J Biol Chem 2001;276:6817-24
   PubMed Web of Science ®Google Scholar
• Shi Y, Sawada J, Sui G, Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 2003;422:735-8
   PubMed Web of Science ®Google Scholar
• Barski A, Cuddapah S, Cui K, High-resolution profiling of histone methylations in the human genome. Cell 2007;129:823-37
   PubMed Web of Science ®Google Scholar
• Yang M, Gocke CB, Luo X, Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase. Mol Cell 2006;23:377-87
   PubMed Web of Science ®Google Scholar
• Lan F, Collins RE, De Cegli R, Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression. Nature 2007;448:718-22
   PubMed Web of Science ®Google Scholar
• Forneris F, Binda C, Vanoni MA, Human histone demethylase LSD1 reads the histone code. J Biol Chem 2005;280:41360-5
   PubMed Web of Science ®Google Scholar
• Lee MG, Wynder C, Bochar DA, Functional interplay between histone demethylase and deacetylase enzymes. Mol Cell Biol 2006;26:6395-402
   PubMed Web of Science ®Google Scholar
• Metzger E, Wissmann M, Yin N, LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 2005;437:436-9
   PubMed Web of Science ®Google Scholar
• Garcia-Bassets I, Kwon YS, Telese F, Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 2007;128:505-18
   PubMed Web of Science ®Google Scholar
• Perillo B, Ombra MN, Bertoni A, DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression. Science 2008;319:202-6
   PubMed Web of Science ®Google Scholar
• Metzger E, Imhof A, Patel D, Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4. Nature 2010;464:792-6
   PubMed Web of Science ®Google Scholar
• Yang M, Culhane JC, Szewczuk LM, Structural basis of histone demethylation by LSD1 revealed by suicide inactivation. Nat Struct Mol Biol 2007;14:535-9
   PubMed Web of Science ®Google Scholar
• Nair SS, Nair BC, Cortez V, PELP1 is a reader of histone H3 methylation that facilitates oestrogen receptor-alpha target gene activation by regulating lysine demethylase 1 specificity. EMBO Rep 2010;11:438-44
   PubMed Web of Science ®Google Scholar
• Biswas D, Milne TA, Basrur V, Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes. Proc Natl Acad Sci USA 2011;108:15751-6
   PubMed Web of Science ®Google Scholar
• Nakamura T, Mori T, Tada S, ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol Cell 2002;10:1119-28
   PubMed Web of Science ®Google Scholar
• Amente S, Bertoni A, Morano A, LSD1-mediated demethylation of histone H3 lysine 4 triggers Myc-induced transcription. Oncogene 2010;29:3691-702
   PubMed Web of Science ®Google Scholar
• Wang J, Hevi S, Kurash JK, The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat Genet 2009;41:125-9
   PubMed Web of Science ®Google Scholar
• Kontaki H, Talianidis I. Lysine methylation regulates E2F1-induced cell death. Mol Cell 2010;39:152-60
   PubMed Web of Science ®Google Scholar
• Yang J, Huang J, Dasgupta M, Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes. Proc Natl Acad Sci USA 2010;107:21499-504
   PubMed Web of Science ®Google Scholar
• Huang J, Sengupta R, Espejo AB, p53 is regulated by the lysine demethylase LSD1. Nature 2007;449:105-8
   PubMed Web of Science ®Google Scholar
• Cho HS, Suzuki T, Dohmae N, Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells. Cancer Res 2011;71:655-60
   PubMed Web of Science ®Google Scholar
• Wang J, Scully K, Zhu X, Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature 2007;446:882-7
   PubMed Web of Science ®Google Scholar
• Macfarlan TS, Gifford WD, Agarwal S, Endogenous retroviruses and neighboring genes are coordinately repressed by LSD1/KDM1A. Genes Dev 2011;25:594-607
   PubMed Web of Science ®Google Scholar
• Rudolph T, Yonezawa M, Lein S, Heterochromatin formation in Drosophila is initiated through active removal of H3K4 methylation by the LSD1 homolog SU(VAR)3-3. Mol Cell 2007;26:103-15
   PubMed Web of Science ®Google Scholar
• Di Stefano L, Ji JY, Moon NS, Mutation of Drosophila Lsd1 disrupts H3-K4 methylation, resulting in tissue-specific defects during development. Curr Biol 2007;17:808-12
   PubMed Web of Science ®Google Scholar
• Katz DJ, Edwards TM, Reinke V, A C. elegans LSD1 demethylase contributes to germline immortality by reprogramming epigenetic memory. Cell 2009;137:308-20
   PubMed Web of Science ®Google Scholar
• Lan F, Zaratiegui M, Villen J, S. pombe LSD1 homologs regulate heterochromatin propagation and euchromatic gene transcription. Mol Cell 2007;26:89-101
   PubMedGoogle Scholar
• Yokoyama A, Takezawa S, Schule R, Transrepressive function of TLX requires the histone demethylase LSD1. Mol Cell Biol 2008;28:3995-4003
   PubMed Web of Science ®Google Scholar
• Su ST, Ying HY, Chiu YK, Involvement of histone demethylase LSD1 in Blimp-1-mediated gene repression during plasma cell differentiation. Mol Cell Biol 2009;29:1421-31
   PubMedGoogle Scholar
• Saleque S, Kim J, Rooke HM, Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1. Mol Cell 2007;27:562-72
   PubMed Web of Science ®Google Scholar
• Hu X, Li X, Valverde K, LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis. Proc Natl Acad Sci USA 2009;106:10141-6
   PubMedGoogle Scholar
• Lin T, Ponn A, Hu X, Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition. Oncogene 2010;29:4896-904
   PubMed Web of Science ®Google Scholar
• Foster CT, Dovey OM, Lezina L, Lysine-specific demethylase 1 regulates the embryonic transcriptome and CoREST stability. Mol Cell Biol 2010;30:4851-63
   PubMed Web of Science ®Google Scholar
• Whyte WA, Bilodeau S, Orlando DA, Enhancer decommissioning by LSD1 during embryonic stem cell differentiation. Nature 2012;482:221-5
   PubMed Web of Science ®Google Scholar
• Adamo A, Sese B, Boue S, LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cells. Nat Cell Biol 2011;13:652-9
   PubMed Web of Science ®Google Scholar
• Cai C, He HH, Chen S, Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1. Cancer Cell 2011;20:457-71
   PubMed Web of Science ®Google Scholar
• Hu Q, Kwon YS, Nunez E, Enhancing nuclear receptor-induced transcription requires nuclear motor and LSD1-dependent gene networking in interchromatin granules. Proc Natl Acad Sci USA 2008;105:19199-204
   PubMed Web of Science ®Google Scholar
• Sun G, Alzayady K, Stewart R, Histone demethylase LSD1 regulates neural stem cell proliferation. Mol Cell Biol 2010;30:1997-2005
   PubMed Web of Science ®Google Scholar
• Sprussel A, Schulte JH, Weber S, Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation. Leukemia 2012
   PubMedGoogle Scholar
• Harris WJ, Huang X, Lynch JT, The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells. Cancer Cell 2012;21:473-87
   PubMed Web of Science ®Google Scholar
• Ram O, Goren A, Amit I, Combinatorial patterning of chromatin regulators uncovered by genome-wide location analysis in human cells. Cell 2011;147:1628-39
   PubMed Web of Science ®Google Scholar
• Kahl P, Gullotti L, Heukamp LC, Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Cancer Res 2006;66:11341-7
   PubMed Web of Science ®Google Scholar
• Schulte JH, Lim S, Schramm A, Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy. Cancer Res 2009;69:2065-71
   PubMed Web of Science ®Google Scholar
• Lv T, Yuan D, Miao X, Over-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancer. PLoS ONE 2012;7:e35065
   PubMed Web of Science ®Google Scholar
• Lim S, Janzer A, Becker A, Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis 2010;31:512-20
   PubMed Web of Science ®Google Scholar
• Hayami S, Kelly JD, Cho HS, Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers. Int J Cancer 2011;128:574-86
   PubMed Web of Science ®Google Scholar
• Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 2007;9:166-80
   PubMed Web of Science ®Google Scholar
• Wouters BJ, Lowenberg B, Erpelinck-Verschueren CA, Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome. Blood 2009;113:3088-91
   PubMed Web of Science ®Google Scholar
• Radich JP, Dai H, Mao M, Gene expression changes associated with progression and response in chronic myeloid leukemia. Proc Natl Acad Sci USA 2006;103:2794-9
   PubMed Web of Science ®Google Scholar
• Goardon N, Marchi E, Atzberger A, Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia. Cancer Cell 2011;19:138-52
   PubMed Web of Science ®Google Scholar
• Somervaille TC, Cleary ML. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Cancer Cell 2006;10:257-68
   PubMed Web of Science ®Google Scholar
• Somervaille TC, Matheny CJ, Spencer GJ, Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells. Cell Stem Cell 2009;4:129-40
   PubMed Web of Science ®Google Scholar
• Lee MG, Wynder C, Schmidt DM, Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. Chem Biol 2006;13:563-7
   PubMed Web of Science ®Google Scholar
• Yang M, Culhane JC, Szewczuk LM, Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine. Biochemistry 2007;46:8058-65
   PubMed Web of Science ®Google Scholar
• Schmidt DM, McCafferty DG. trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1. Biochemistry 2007;46:4408-16
   PubMed Web of Science ®Google Scholar
• Binda C, Valente S, Romanenghi M, Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and LSD2. J Am Chem Soc 2010;132:6827-33
   PubMed Web of Science ®Google Scholar
• Mimasu S, Umezawa N, Sato S, Structurally designed trans-2-phenylcyclopropylamine derivatives potently inhibit histone demethylase LSD1/KDM1. Biochemistry 2010;49:6494-503
   PubMed Web of Science ®Google Scholar
• Benelkebir H, Hodgkinson C, Duriez PJ, Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors. Bioorg Med Chem 2011;19(12):3709-16
   PubMed Web of Science ®Google Scholar
• Guibourt N. Phenylcyclopropylamine derivatives and their medical use. WO2010084160; 2010
   Google Scholar
• Culhane JC, Szewczuk LM, Liu X, A mechanism-based inactivator for histone demethylase LSD1. J Am Chem Soc 2006;128:4536-7
   PubMed Web of Science ®Google Scholar
• Culhane JC, Wang D, Yen PM, Comparative analysis of small molecules and histone substrate analogues as LSD1 lysine demethylase inhibitors. J Am Chem Soc 2010;132:3164-76
   PubMed Web of Science ®Google Scholar
• Huang Y, Greene E, Murray Stewart T, Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes. Proc Natl Acad Sci USA 2007;104:8023-8
   PubMed Web of Science ®Google Scholar
• Huang Y, Stewart TM, Wu Y, Novel oligoamine analogues inhibit lysine-specific demethylase 1 and induce reexpression of epigenetically silenced genes. Clin Cancer Res 2009;15:7217-28
   PubMed Web of Science ®Google Scholar
• Sharma SK, Wu Y, Steinbergs N, (Bis)urea and (bis)thiourea inhibitors of lysine-specific demethylase 1 as epigenetic modulators. J Med Chem 2010;53:5197-212
   PubMed Web of Science ®Google Scholar
• Gooden DM, Schmidt DM, Pollock JA, Facile synthesis of substituted trans-2-arylcyclopropylamine inhibitors of the human histone demethylase LSD1 and monoamine oxidases A and B. Bioorg Med Chem Lett 2008;18:3047-51
   PubMed Web of Science ®Google Scholar
• Ueda R, Suzuki T, Mino K, Identification of cell-active lysine specific demethylase 1-selective inhibitors. J Am Chem Soc 2009;131:17536-7
   PubMedGoogle Scholar
• Wang J, Lu F, Ren Q, Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties. Cancer Res 2011;71:7238-49
   PubMed Web of Science ®Google Scholar
• Willmann D, Lim S, Wetzel S, Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor. Int J Cancer 2012
   PubMedGoogle Scholar
• Pollock JA, Larrea MD, Jasper JS, lysine-specific histone demethylase 1 inhibitors control breast cancer proliferation in eralpha-dependent and -independent manners. ACS Chem Biol 2012;7:1221-31
   PubMed Web of Science ®Google Scholar
• Singh MM, Manton CA, Bhat KP, Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors. Neuro Oncol 2011;13:894-903
   PubMed Web of Science ®Google Scholar
• Somervaille TC, Cleary ML. Grist for the MLL: how do MLL oncogenic fusion proteins generate leukemia stem cells? Int J Hematol 2010;91:735-41
   PubMedGoogle Scholar
• Grimwade D, Hills RK, Moorman AV, Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 2010;116:354-65
   PubMed Web of Science ®Google Scholar
• Schenk T, Chen WC, Gollner S, Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia. Nat Med 2012;18:605-11
   PubMed Web of Science ®Google Scholar
• Kim T, Buratowski S. Dimethylation of H3K4 by Set1 recruits the Set3 histone deacetylase complex to 5' transcribed regions. Cell 2009;137:259-72
   PubMed Web of Science ®Google Scholar
• Mimasu S, Sengoku T, Fukuzawa S, Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25 A. Biochem Biophys Res Commun 2008;366:15-22
   PubMed Web of Science ®Google Scholar
• Su AI, Wiltshire T, Batalov S, A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 2004;101:6062-7
   PubMed Web of Science ®Google Scholar
• Ernst J, Kheradpour P, Mikkelsen TS, Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011;473:43-9
   PubMed Web of Science ®Google Scholar